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Background: Brazil has a multiethnic population with a high diversity of
hemoglobinopathies. While screenings for beta-globin mutations are far more  com-
mon, alterations affecting alpha-globin genes are usually more silent and less well known.
The aim of this study was to describe the results of a screening program for alpha-globin
gene mutations in a representative sample of the Southeastern Brazilian population.
Methods: A total of 135,000 individuals, including patients with clinical suspicion of
hemoglobinopathies and their family members, randomly chosen individuals submitted
to  blood tests and blood donors who were abnormal hemoglobin carriers were analyzed.
The variants were screened by alkaline and acid electrophoreses, isoelectric focusing and
cation-exchange high performance liquid chromatography (HPLC) and the abnormal chains
were  investigated by reverse-phase high performance liquid chromatography (RP-HPLC).
Mutations were identiﬁed by molecular analyses, and the oxygen afﬁnity, heme–heme coop-
erativity and Bohr effect of the variants were evaluated by functional tests.Results: Four new and 22 rare variants were detected in 98 families. Some of these vari-
ants were found in co-inheritance with other hemoglobinopathies. Of the rare hemoglobins,
Hasharon, Stanleyville II and J-Rovigo were the most common, the ﬁrst two being S-like and
associated with alpha-thalassemia.
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Conclusion: The variability of alpha-globin alterations reﬂects the high degree of racial
miscegenation and an intense internal migratory ﬂow between different Brazilian regions.
This diversity highlights the importance of programs for diagnosing hemoglobinopathies
and preventing combinations that may lead to important clinical manifestations in
multiethnic populations.
© 2015 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.Introduction
Alpha-globin chain variants are the result of point mutations
(single nucleotide polymorphisms – SNPs) or small base inser-
tions or deletions that affect the region encoding the 1 and 2
genes, thus resulting in amino acid substitutions in the protein
chains or even elongated chains.1
More  than 400 structural changes in the alpha-chain have
been described to date2, most of which are caused by simple
DNA base substitutions with the corresponding substitutions
of amino acid residues in the protein. Many  of these alter-
ations do not result in clinical symptoms; however, some
can affect the function of the hemoglobin (Hb) molecule,
resulting in erythrocytosis or cyanosis, and its stability, caus-
ing hemolytic anemia.3 In addition, there are elongated
and extremely unstable variants that lead to thalassemia
phenotypes.4
The Hemoglobinopathy Laboratory of the Hospital das Clin-
icas, Universidade Estadual de Campinas (UNICAMP), São
Paulo, Southeastern Brazil is a referral laboratory for the diag-
nosis of hemoglobinopathies. This paper summarizes the
alpha-chain structural variants identiﬁed in the laboratory
during its 30 years of existence.
Methods
To date, 135,000 cases have been investigated in this labora-
tory. This population sample includes patients with clinical
suspicion of hemoglobinopathies and their family members,
randomly chosen individuals who had blood tests and blood
donors who  were carriers of hemoglobin variants. The local
ethics committee approved this study and the subjects or
their legal guardians gave informed consent for participation.
Structural changes in the alpha-chain were identiﬁed in 124
individuals from 98 different families (approximately 0.1% of
the analyzed cases).
Peripheral blood samples were collected in tubes con-
taining EDTA, and hematological analyses were carried out
using an automated counter (Sysmex XE 2100, Sysmex, Kobe,
Japan). Hb variants were identiﬁed and characterized by elec-
trophoresis on cellulose acetate at pH 8.9 and agar gel at
pH 6.0, isoelectric focusing (RESOLVE Neonatal Hemoglobin
Test Kit, PerkinElmer Wallace, Akron, OH, USA) and cation
exchange high performance liquid chromatography (HPLC)
(VARIANT II, Bio-Rad Laboratories, Hercules, CA, USA). Abnor-
mal  globin chains were identiﬁed by reverse phase HPLC
(RP-HPLC) (Waters Alliance HPLC System, Waters, Milford, MA,USA). Stability tests (heat stability and stability in n-butanol
and in isopropanol) and solubility tests were also carried out,
as well as an investigation of Heinz bodies and Hb H inclusion
bodies in red cells.5
Functional studies were carried out by plotting the
oxygen–hemoglobin dissociation curve at different pHs to
measure the Bohr effect and evaluate heme–heme cooper-
ativity of the globin chains in the presence and absence of
allosteric effectors.1,5–7
Genomic DNA samples were extracted from peripheral
blood leukocytes, initially by organic methods8 and, more
recently using a speciﬁc kit (Blood Genomic Prep Mini
Spin, GE Healthcare, UK). Alpha-globin genes were selec-
tively ampliﬁed by polymerase chain reaction (PCR) according
to the method described by Dodé et al.9 and sequenced
using an automated technique (ABI PRISM 377 DNA Auto-
mated Sequencer, Applied BioSystems, Foster City, CA,
USA). Mutations were conﬁrmed by sequencing the oppo-
site DNA strand, family analysis and enzyme restriction
analysis, whenever possible. The presence of concomitant
deletional alpha-thalassemia was investigated by multiplex
PCR and gap PCR.10,11 The most common non-deletional
alpha-thalassemic mutations were also investigated when
these were suspected.12,13
Results
Four new alpha-chain variants (Table 1) and 22 rare variants
(Table 2) were detected, ﬁve of the latter concomitantly with
other structural or thalassemic mutations.
New  variants
The four new variants were identiﬁed in 13 individuals
belonging to six different families (Table 1). None resulted
in signiﬁcant hematological or clinical abnormalities in their
carriers.
Hb Campinas [HBA2:c.80C>T p.Ala26Val] was ﬁrst
described in a nine-year-old boy and his mother and
later was observed in three related individuals during a
hemoglobinopathy screening program.14
Hb Boa Esperanc¸a [HBA2:c.50A>C p.Lys16Thr] was identi-
ﬁed in two unrelated individuals. Functional studies showed
that the stripped hemolysate of this Hb had less afﬁnity for
oxygen than Hb A but that the addition of inositol hexaphos-
phate (IHP) to the stripped hemolysate resulted in increased
afﬁnity. This abnormal function, however, may be compen-
sated in vivo by a higher proportion of normal Hb.15
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Table 1 – New alpha-globin variants identiﬁed.
New variant No. of
families/No. of
cases
Mutation -genotype Clinical manifesta-
tions/hematological
alterations
Hb Boa Esperanc¸a  2/2 HBA2:c.50A>C p.Lys16Thr Boa  Esperanc¸a/ No
Hb Campinas 2/5 HBA2:c.80C>T p.Ala26Val Campinas/ No
Hb Bom Jesus da Lapa 1/3 HBA1:c.92A>C p.Glu30Ala B Jesus  da  Lapa/ No
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Total 6/13
Two new mutations resulting in substitutions of the same
mino acid residue (glutamic acid at position 30) by chem-
cally similar residues were also identiﬁed: Hb Bom Jesus da
apa [HBA1:c.92A>C p.Glu30Ala] and Hb Itapira [HBA1:c.92A>T
.Glu30Val]. In both, a polar amino acid residue was replaced
y a nonpolar one, but no clinical manifestations were
bserved in the carriers. Hb Bom Jesus da Lapa was detected in
hree related heterozygous individuals of indigenous descent.
b Itapira, for which the mutation was found in a triplicate
lpha allele (anti-3.7) and which accounted for only 5.5% of
otal Hb production, was found in three related individuals.15
are  variants
wenty-two rare alpha-chain variants were detected in 111
ndividuals from 92 different families. Of these, the most
revalent was Hb Hasharon (41 families, 45 cases) (Table 2),
orresponding to 44.6% of the families with rare alpha-chain
tructural variants. The second most prevalent variant was
b Stanleyville II (15 families, 17 cases – Table 2), correspond-
ng to 16.3% of the carrier families. In third place was Hb
-Rovigo, with nine affected families (10 cases) (Table 2) and
orresponding to 9.8% of the carrier families with rare alpha-
lobin variants. Hb Hasharon and Hb Stanleyville II resulted
n slightly altered hematological ﬁndings (hypochromia and
icrocytosis), which may be explained by the fact that they
ere in association with the −3.7 deletion.
Hb Hasharon was found in heterozygosis (38 families, 41
ndividuals), in homozygosis (1 case) and in association with
ther mutations of globin genes. In one family, two individ-
als had both Hb Hasharon and Hb Rio Claro [HBA2:c.142G>C
.Asp47His; HBB:c.100G>A p.Val33Met], a beta-chain variant
ewly described in this laboratory.16 Both individuals had
icrocytosis and hypochromia (Table 2). In another family,
b Hasharon was detected with one + (IVS-I-110) and one
0 (CD39) allele in the same individual, who presented with a
ypical clinical course of thalassemia intermedia (Table 2).17
Like Hb Hasharon, Hb Stanleyville II was found con-
omitantly with other structural variants in two unrelated
ndividuals (Table 2). In the ﬁrst, it was present with Hb S,
he most common structural variant in the Brazilian popu-
ation. In the second case, there was a combination of Hb
tanleyville II and Hb Campinas [HBA1:c.237C>G p.Asn78Lys;
BA2:c.80C>T p.Ala26Val] and the individual also had micro-
18ytosis and hypochromia (Table 2). In both cases, the red
lood cells of the carriers showed microcytosis and hypochro-
ia  as the Hb Stanleyville II mutation was associated with
lpha-thalassemia (−3.7 deletion). p.Glu30Val Itapira/ No
Hb G-Norfolk was identiﬁed in combination with 0 (CD39)
thalassemia [HBA2:c.256G>A p.Asp85Asn; HBB:c.118C>T
p.Gln39Stop] in two related individuals resulting in microcy-
tosis and hypochromia (Table 2).
Hb Chelsea [HBA2:c.116C>T p.Thr38Ile] was found in two
related individuals, one with erythrocytosis and the other
without any abnormal hematological ﬁndings (Table 2).
Conversely, Hb Icaria [HBA2:c.427T>A p.Stop142Lys] was
identiﬁed in combination with a common 0 thalassemia
determinant, the ()20.5 allele. Hb Icaria (X142K) is an elongated
chain with 31 extra residues and a change in the C-terminal
region of the protein [(142)Lys-Ala-Gly-Ala-Ser-Val-Ala-Val-
Pro-Pro-Ala-Arg-Trp-Ala-Ser-Gln-Arg-Ala-Leu-Leu-Pro-Ser-
Leu-His-Arg-Pro-Phe-Leu-Val-Phe-(172)Glu-COOH]. In this
case, the elongated and unstable alpha-chain in association
with the −()20.5 deletion, resulted in Hb H disease with high
levels of Hb H and Hb Bart’s (14.7% and 19.0%, respectively)
(Table 2).4
The other rare alpha-globin variants (Table 2) were found in
blood donors and asymptomatic individuals participating in a
hemoglobinopathy screening program, which also identiﬁed
most of the cases of Hb Hasharon, Hb Stanleyville and Hb J-
Rovigo.
Discussion
Hb variants and thalassemias have a diverse geographic dis-
tribution in Brazil as they are very closely related to the ethnic
origins of the population and the colonization process that
took place between the 16th and 19th centuries. The largest
ethnical inﬂuence during the colonization of Brazil was due to
Portuguese and African immigrants.
Brazil has the largest Black population in South America,
primarily as a result of the African slave trade which was
responsible for some 3.6 million black people entering the
country from the 16th century onwards, particularly to the
Northeast and Southeast. In the 19th century, other popula-
tions began to arrive, most notably Italian immigrants, who
came in large numbers to settle in the South and Southeast.
This miscegenation was also inﬂuenced by various migra-
tions from other European (Spain, Germany, Holland, Russia
and Poland), Asian (China, Japan and Korea) and Middle East-
ern countries, all of which contributed to the formation of
the Brazilian population. In addition, internal migratory ﬂows
between the populations of different Brazilian states led to
miscegenation between all these population groups.19
This miscegenation has contributed to the high preva-
lence of hemoglobinopathies, reﬂecting the racial diversity
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Table 2 – Rare alpha-globin variants detected.
Hb variant Co-inheritance No. of
families/No.
of cases
Mutation -Genotype Clinical
manifesta-
tions/hematological
alterations
Hb J-Paris-I 2/2 HBA2:c.38C>A p.Ala12Asp J-Paris-I/ No
Hb I-Interlaken 1/1 HBA2:c.47G>C p.Gly15Asp I-Interlaken/ No
Hb Chelsea 1/2 HBA2:c.116C>T p.Thr38Ile Chelsea/ 1 of the carriers with
polycythemia
1 asymptomatic
carrier
Hb Hasharon 38/41 HBA2:c.142G>C p.Asp47His −Hasharon/ Microcytosis and
hypochromia
Hb Hasharon 1/1 HBA2:c.142G>C p.Asp47His −Hasharon/−Hasharon Microcytosis,
hypochromia and
polycythemia
Hb Hasharon +
Hb Rio Claro
1/2  HBA2:c.142G>C p.Asp47His;
HBB:c.100G>A p.Val33Met
−Hasharon/ Microcytosis and
hypochromia
Hb Hasharon +
+ IVS-I-
110 + 0CD39
1/1  HBA2:c.142G>C p.Asp47His;
HBB:c.93-21G>A;
HBB:c.118C>T p.Gln39Stop
−Hasharon/ Thalassemia
intermedia clinical
feature
Hb J-Rovigo 9/10 HBA2:c.161C>A p.Ala53Asp J-Rovigo/ No
Hb Shaare
Zedek
1/1  HBA2:c.169A>G p.Lys56Glu Shaare Zedek/ No
Hb Pontoise 1/2 HBA2:c.191C>A p.Ala63Asp Pontoise/ No
Hb Danesh-
gah Tehran
4/5  HBA2:c.218A>G p.His72Arg Daneshgah  Tehran/ No
Hb G-Norfolk +
0CD39
1/2  HBA2:c.256G>A
p.Asp85Asn;
HBB:c.118C>T p.Gln39Stop
G-Norfolk/ Microcytosis and
hypochromia
Hb Cemenelum 1/2 HBA2:c.277C>T p.Arg92Trp Cemenelum/ No
Hb Setif 1/5 HBA2:c.283G>T p.Asp94Tyr Setif/ No
Hb Westmead 1/1 HBA2:c.369C>G p.His122Gln Westmead/ No
Hb Jackson 1/1 HBA2:c.384G>C p.Lys127Asn Jackson/ No
Hb Icaria 1/1* HBA2:c.427T>A
p.Stop142Lys
Icaria/ No
Hb Icaria +
−()20.5hetero
1/1*  HBA2:c.427T>A
p.Stop142Lys
Icaria/−()20.5 Hb H Disease
Hb Douala 1/2 HBA1:c.11C>T p.Ser3Phe Douala/ No
Hb Kurosaki 3/3 HBA1:c.22A>G p.Lys7Glu Kurosaki/ No
Hb Ube-2 1/1 HBA1:c.205A>G p.Asn68Asp Ube-2/ No
Hb G-Pest 1/1 HBA1:c.223G>A p.Asp74Asn G-Pest/ No
Hb
Stanleyville-
II
13/15 HBA1:c.237C>G p.Asn78Lys −Stanleyville-II/ Microcytosis and
hypochromia
Hb Stanleyville-II +
Hb S
1/1  HBA1:c.237C>G p.Asn78Lys;
HBB:c.20A>T p.Glu6Val
−Stanleyville-II/ Microcytosis and
hypochromia
Hb Stanleyville-II +
Hb Campinas
1/1  HBA1:c.237C>G p.Asn78Lys;
HBA2:c.80C>T p.Ala26Val
−Stanleyville-II/Campinas Microcytosis and
hypochromia
Hb Iwata 1/1 HBA1:c.263A>G p.His87Arg Iwata/ No
Hb Tamano 2/4 HBA1:c.269A>G p.His89Arg Tamano/ No
Hb Sunshine
Seth
1/1  HBA1:c.283G>C p.Asp94His Sunshine  Seth/ No
Total 22 92/111* Related individuals.
in each region of the country.19,20 Hence, any investigation
into the prevalence of hemoglobinopathies in Brazil must
take into account the historical processes involved in the
ethnic make-up of the population. To date, no evidence of
the existence of hemoglobinopathies in pre-Columbian Amer-
ica has been found, suggesting that these were brought
to the Americas and to Brazil by the various migratory
ﬂows.20,21Because it has the most developed economy in the coun-
try and is responsible for over half of the country’s output,
the southeast of Brazil is the main destination for migrants
from other countries and Brazilian regions. The State of São
Paulo in particular attracts the most immigrants as, in addition
to its economic strength, it has relatively good social indi-
cators. Indeed, the metropolitan region of Campinas, where
UNICAMP is located, has the highest human development
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[alpha16(A14)Lys –> Thr (alpha2)]. Hemoglobin.rev bras hematol hemot
ndex in Brazil according to United Nations Development Pro-
ram (UNDP) data.22 The population in this part of Brazil
s very mixed, mainly made up of individuals of Italian,
ortuguese, Amerindian, African, Arabic, German, Spanish,
apanese and Chinese descent.
This miscegenation is reﬂected in the great variety of
nusual hemoglobins identiﬁed in the cases referred to our
aboratory: Hb Stanleyville II, Hb Douala and Hb Chelsea
re from the African continent2,23,24; Hb Jackson is found
n Black Americans from Southwestern United States25; Hb
estmead, Hb Kurosaki, Hb Ube-2, Hb Iwata and Hb Tamano
re of Asian origin2,26–29; Hb Hasharon, Hb Shaare Zedek,
b Daneshgah-Tehran and Hb Setif are from the Middle
ast2,30–32; Hb J-Paris, Hb I-Interlaken, Hb J-Rovigo, Hb Pontoise,
b Cemenelum, Hb G-Norfolk and Hb Sunshine Seth are found
n European populations33–39; and Hb Icaria and Hb G-Pest
re from Eastern Europe.40,41 In this respect, different alpha-
lobin variants have been found in other Brazilian regions,
uch as in the state of Minas Gerais, where Hb Etobicoke, Hb
ttawa and Hb St. Luke’s were detected for the ﬁrst time in
razil.42
Thus, despite the individuals analyzed here belonging to
 hospital sample and not reﬂecting the general population,
he variety of hemoglobins identiﬁed is the result of the con-
ributions made by the different population groups to the
thnic make-up of the Brazilian population and highlights the
mportance of programs for diagnosing hemoglobinopathies
n Brazil, particularly because of the large number of immi-
rants from countries with high risk for hemoglobinopathies.
he combination of alpha-chain variants with other struc-
ural or thalassemic mutations can result in clinically relevant
henotypes, highlighting the importance of characterizing
emoglobins.
onclusion
he ﬁndings presented here corroborate the high degree
f diversity among Hb variants in the Brazilian popula-
ion, in which miscegenation has increased the likelihood
f rare hemoglobinopathies. Identiﬁcation of Hb variants
an therefore make a signiﬁcant contribution to anthropo-
ogical studies of the different groups that make up the
razilian population and to an assessment of the incidence
f Hb variants, which, in combination with other com-
on  hemoglobinopathies, such as Hb S, Hb C and alpha-
nd beta-thalassemia, represent a public health problem in
razil. This information could be used by individuals and
heir families in genetic counseling. In addition, identiﬁcation
nd characterization of new hemoglobin structural variants
ill contribute to a better understanding on the relation
etween structure and function of this and other important
roteins.
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